070-000-341 Ellagic Acid, CAS 476-66-4

SKU: 070-000-341 Category:
Get A Quote






  I would like to join the mailing list to receive updates from Stanford Chemicals.
*: e-mail address with your company's domain name is preferred. Otherwise, we may not be able to process your inquiry.

Synonyms Gallogen, Lagistase, TBBD
Keywords Anti-oxidation, whitening
Related products Capryloyl Salicylic Acid, Nicotinamide Ribosideβ-Nicotinamide mononucleotideVitamin CGrape Seed Extract
Description

Description

Ellagic Acid Specifications

Product Name Ellagic Acid
CAS Registry Number 476-66-4
Molecular Formula C14H6O8
Molecular Weight 302.2 g/mol
Purity 99 %
Appearance White powder
Package 1kg-25kg
Shelf life 2 years
Functions Anti-hyperplasia and anti-oxidation

Ellagic Acid Description

Ellagic Acid is a polyphenolic antioxidant that is abundant in many fruits, vegetables, plant bark, and peels. It has anti-carcinogenic, anti-mutagenic, anti-inflammatory, and organ-preserving properties, presumably related to its ability to alter cytochrome P450 activity and improve metabolism and clearance of xenobiotics, as well as alter immune function.

Ellagic acid is used for cancer, dark skin patches on the face (melasma), memory and thinking skills (cognitive function), diabetes, and many other purposes.

Ellagic Acid

Ellagic Acid Applications

  • Prevent skin darkening in skincare products

Reference:

  1. Selvi, B.R., Batta, K., Kishore, A.H., et al. Identification of a novel inhibitor of coactivator-associated arginine methyltransferase 1 (CARM1)-mediated methylation of histone H3 Arg-17. The Journal of Biological Chemisty 285(10), 7143-7152 (2010).
  2. Paluszczak, J., Krajka-Kuzniak, V., and Baer-Dubowska, W. The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicology Letters 192(2), 119-125 (2010).
  3. Allen, C.T., Peden-Adams, M.M., EuDaly, J., et al. Subchronic exposure to ellagic acid impairs cytotoxic T-cell function and suppresses humoral immunity in mice. Immunopharmacol.Immunotoxicol. 25(3), 409-422 (2003).